Semnur Pharmaceuticals, Inc. ( "Semnur" ) , a Majority-Owned Subsidiary of Scilex Holding Company ( Nasdaq: SCLX, "Scilex" ) , and Denali Capital Acquisition Corp. Announce Approval from Denali's Shareholders of the Previously Announced Business Combination - Scilex Holding ( NASDAQ:SCLX ) , Scilex Holding ( NASDAQ:SCLXW )

Scilex Holding Company ( Nasdaq: SCLX ) Announces Its Majority-Owned Subsidiary, Semnur Pharmaceuticals, Inc. ( "Semnur" ) , and Denali Capital Acquisition Corp. Have Entered into a Purchase Agreement with an Investor for a $20 Million Private Placement at $16.00 per share and Jaisim Shah, Scilex's CEO and President, Will be Dedicated to Semnur on a Full Time Basis to Rapidly Advance SP-102 to Regulatory Approval and Commercialization for the Treatment of Lumbosacral Radicular Pain ( LRP ) /Sciatica - Scilex Holding ( NASDAQ:SCLX ) , Scilex Holding ( NASDAQ:SCLXW )

Scilex Holding Company ( Nasdaq: SCLX ) Announces Its Majority-Owned Subsidiary, Semnur Pharmaceuticals, Inc. ( "Semnur" ) , and Denali Capital Acquisition Corp. Have Entered into a Purchase Agreement with an Investor for a $20 Million Private Placement at $16.00 per share and Jaisim Shah, Scilex's CEO and President, Will be Dedicated to Semnur on a Full Time Basis to Rapidly Advance SP-102 to Regulatory Approval and Commercialization for the Treatment of Lumbosacral Radicular Pain ( LRP ) /Sciatica

Scilex Holding Company ( Nasdaq: SCLX ) Announces Effectiveness of Registration Statement on Form S-4 for the Proposed Business Combination of Denali Capital Acquisition Corp. and Semnur Pharmaceuticals, Inc., a Majority-Owned Subsidiary of Scilex - Scilex Holding ( NASDAQ:SCLXW ) , Scilex Holding ( NASDAQ:SCLX )

Scilex Holding Company ( Nasdaq: SCLX ) Announces Effectiveness of Registration Statement on Form S-4 for the Proposed Business Combination of Denali Capital Acquisition Corp. and Semnur Pharmaceuticals, Inc., a Majority-Owned Subsidiary of Scilex

Scilex Holding Company Announces Deferral of Record Date for its Previously Announced Dividend of Preferred Stock Exchangeable for up to 10% of Scilex's Ownership Interest in Semnur Pharmaceuticals, Inc., its Wholly Owned Subsidiary from May 2, 2025 to a future date to be determined by the Board - Scilex Holding ( NASDAQ:SCLX ) , Scilex Holding ( NASDAQ:SCLXW )

Scilex Holding Company Announces Deferral of Record Date for its Previously Announced Dividend of Preferred Stock Exchangeable for up to 10% of Scilex's Ownership Interest in Semnur Pharmaceuticals, Inc., its Wholly Owned Subsidiary from May 2, 2025 to a future date to be determined by the Board

Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business Combination

Scilex Holding Company Announces Publication on GLOPERBA® Dosing Adjustments in Peer-Review Journal - Scilex Holding ( NASDAQ:SCLX ) , Scilex Holding ( NASDAQ:SCLXW )